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SUMMARY – The aim of this study was to determine the relationship between the risk factors 
(age, obesity, hypertension, hyperlipidemia, smoking, consumption of alchohol and drugs, positive 
family history, and exposure to sunlight), coping with stress, psychological well-being and age-re-
lated macular degeneration (ARMD). Forty patients with ARMD (case group) and 63 presbyopes 
(control group) participated in the study. Patient data were collected through general information 
questionnaire including patient habits, the COPE questionnaire that showed the way the patients 
handling stress, and the GHQ that analyzed the psychological aspects of their quality of life. These 
questionnaires were administered to the patients during ophthalmologic examination. The study 
involved 46 (44.66%) men and 57 (55.33%) women. Statistical analysis showed that the major risks 
for the development of ARMD were elevated cholesterol, triglycerides and LDL cholesterol in pla-
sma. A significantly higher number of ARMD patients had a positive family history when compared 
with presbyopes. This study showed presbyopes to cope with emotional problems significantly better 
and to have a lower level of social dysfunction when compared with ARMD patients. However, it 
is necessary to conduct further studies in a large number of patients to determine more accurately 
the pathophysiological mechanisms of metabolic factors as well as the impact of the disease on the 
quality of life in patients with ARMD.
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Introduction
Age-related macular degeneration (ARMD) is a 
progressive condition that leads to severe central vision 
loss by damaging the photoreceptor cell layer in the 
macula. ARMD occurs mainly in people older than 
60 years and affects 30 to 50 million elderly individu-
als per year1-3. The clinical and histopathologic sign of 
ARMD is macular atrophy with drusen, discrete yel-
low lesions in the subretinal area3. Progression of dry 
ARMD characterized with drusen leads to geograph-
ic atrophy, while the wet form is recognized by retinal 
detachment from other layers, hemorrhage, and scar-
ring of the retinal pigment epithelium (RPE)4. Other 
significant risk factors, besides age, include hyperten-
sion, hyperlipidemia, genetic factors, oxidative stress, 
smoking, consumption of alcohol, and the use of 
drugs5-9. Speaking of cardiovascular risk factors, stud-
ies found that smoking increased the risk of ARMD 
by elevating the level of oxidative stress and injuries 
in the blood vessels, and that hypertension was the 
most frequent cardiovascular risk factor for the de-
velopment of ARMD10,11. Oxidative stress is defined 
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as an imbalance between the formation and removal 
of reactive oxygen species (ROS)12. In addition, nu-
merous studies have shown that ROS may play a role 
in the pathogenesis of ARMD by causing damage to 
the cell membrane of retinal rods and cones13. There 
are opposite attitudes about hypertension as a risk fac-
tor because some studies revealed that hypertension 
was not or was rarely associated with the genesis of 
ARMD14,15. However, there are studies that proved 
an existing correlation between hypertension and the 
progression of ARMD, especially in its wet form1,14. 
Dyslipidemia is a major cause of morbidity and it is 
the leading contributor to mortality worldwide16. Lip-
id level imbalance, i.e. high plasma concentrations of 
low-density lipoproteins (LDL), low concentrations of 
high-density lipoproteins (HDL), and elevated plasma 
triglyceride concentrations, has a huge impact on many 
organs of the body and it has been connected to a wide 
range of eye diseases such as ARMD17,18. There is clear 
evidence for heritability of ARMD, demonstrated in 
several genetic studies, and a strong association was 
found with the polymorphism complement factor H 
(CFH) gene8. Quality of life is defined in many dif-
ferent ways, and it can be understood and tested in 
different ways. Quality of life can be described as the 
individuals’ perception of satisfaction with their lives 
and in most cases it is associated with health. How-
ever, its meaning is much wider including physical 
health, psychological state, level of independence, 
social relationships, and personal beliefs19. According 
to the literature, only a few researches show that de-
pression and a restricted number of daily activities that 
can be accomplished without assistance from the oth-
ers significantly reduce the quality of life of ARMD 
patients20-22. In elderly people affected with ARMD, 
the low quality of life is related to greater emotional 
stress, social isolation, poor general health and func-
tional status, which impacts the patients’ mobility and 
autonomy. Behavioral psychotherapy programs and 
psychosocial support have shown great results in re-
ducing emotional distress, consequently improving the 
quality of life by enabling these patients to live more 
independently23-27. Based on previous research, the 
purpose of this study was to reveal the prevalence of 
risk factors in patients with ARMD as well as the re-
lationship between chronic stress, psychological aspect 
of life quality and ARMD.
Patients and Methods
This case-control study was conducted in the pe-
riod from September 1, 2012 until March 1, 2013, 
at the Clinical Department of Ophthalmology, Mo-
star University Hospital. Forty patients who under-
went complete ophthalmologic examination were di-
agnosed to have ARMD and they were recruited as 
cases, while 63 individuals with presbyopia matched 
by age (±2 years) and sex were recruited as controls. 
Excluding criteria for participation in the study were 
eye diseases that can damage vision, such as kerati-
tis, corneal dystrophy, cataract, glaucoma and diabetic 
retinopathy. The following parameters were considered 
to be associated with ARMD: age, obesity, hyperten-
sion, hyperlipidemia, smoking, consumption of alcho-
hol, positive family history of ARMD, exposure to 
sunlight, use of nonsteroidal anti-inflammatory drugs 
(NSAIDs), chronic stress, and the psychological as-
pect of the quality of life. Data were collected using 
the following instruments: 1) questionnaire on gen-
eral information such as age, body mass index (BMI), 
consumption of alcohol, cigarettes and NSAIDs, 
nutrition, professional orientation toward harmful 
effect of sun exposure (i.e. landscape and construc-
tion workers), and positive family history of ARMD 
affecting first-degree relatives; 2) Coping Orienta-
tion to Problems Experienced (COPE) questionnaire 
with 48 items describing people’s reaction to differ-
ent life difficulties, stress and upseting situations. It 
has five subscales: persistence, emotions, avoidance, 
fun and disarrangement. Answers were analyzed 
on Likert 5-point scale. Participants were asked to 
choose answers from 1 to 5, with 1 representing ab-
solute disagreement and 5 indicating complete agree-
ment. Items are summed for each subscale. Higher 
scores on a subscale indicate greater use of that coping 
mechanism28; and 3) General Health Questionnaire 
(GHQ ) with 28 questions, where subjects were asked 
to compare their recent psychological state with their 
usual state. Patients would choose answers from 1 to 
5 describing their psychological well-being. It is also a 
tool for measuring common mental health problems, 
i.e. depression, anxiety, somatic symptoms and social 
alienation. Answers were analyzed on Likert 4-point 
scale, with 1 representing not at all and 4 much more 
than usual. A higher score meant a poorer psychologi-
cal well-being of patients29. 
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An informed consent was obtained from study 
subjects, and all practices and procedures were in ac-
cordance with the Declaration of Helsinki and were 
approved by the Mostar University Hospital Ethics 
Committee. Questionnaires were completed by all 
participants during their visit to the ophthalmologist.
Statistical analysis was performed using the SPSS 
for Windows software (version 13.0, SPSS Inc., Chi-
cago, Illinois, USA) and Microsoft Excel (version 11, 
Microsoft Corporation, Redmond, WA, USA). Nor-
mality of distribution for the equality of continuous 
variables was tested by Kolmogorov-Smirnov test and 
was presented with arithmetic mean and standard de-
viation (SD). For comparison of equality of the con-
tinuous variables, the t-test was used. Chi-square test 
was used for analysis of nominal variables, but when 
lower frequency was expected, Fisher exact test was 
introduced. Significant difference between the groups 
was set at P<0.05.
Results
This case control study was conducted in the pe-
riod from September 1, 2012 until March 1, 2013. We 
examined 103 patients in total: 40 patients as cases 
(ARMD patients) and 63 as controls (presbyopes). 
There were 46 (44.66%) men and 57 (55.33%) wom-
en. The female to male ratio was 1.2:1.0 (χ2 test=0.75; 
P=0.385). The mean age of all study subjects was 
64±9.8 (age range 55-84) years.
Table 1 shows BMI values and hypertension 
prevalence in patients with ARMD (cases). Controls 
were patients with presbyopia. The number of patients 
with elevated BMI was 26 (65.0%) in ARMD group 
and 47 (74.6%) in control group. Statistical analy-
sis showed no significant between-group difference 
(χ2=1.09; P=0.296). Hypertension was present in 24 
(60.0%) patients with ARMD and 29 (46.0%) pa-
tients with presbyopia. Statistical analysis yielded no 
significant between-group difference either (χ2=1.91; 
P=0.167).
Table 2 shows the levels of body lipids (triglycerides, 
cholesterol, LDL cholesterol and HDL cholesterol) 
in patients with ARMD and presbyopia. The number 
of patients with elevated levels of plasma triglycer-
ides was significantly higher in ARMD group (n=23; 
57.5%) than in control group (n=16; 25.4%) (χ2=10.72; 
P=0.001). The number of patients with high plasma 
cholesterol concentration was also significantly higher 
in patients with ARMD (n=29; 72.5%) in comparison 
with control group (n=25; 39.7%) (χ2=10.56; P=0.001). 
There was no significant difference between the study 
groups with respect to the number of patients with 
normal or elevated HDL level (χ2=2.23; P=0.135).
High plasma concentration of LDL was present in 26 
(65.0%) ARMD patients and 13 (20.6%) presbyopia 
patients, yielding a significant between-group differ-
ence (χ2=12.09; P=0.001).
Table 1. Prevalence of hypertension and increase in body 








<25 14 (35.0) 16 (25.4)
1.09 0.296
≥25 26 (65.0) 47 (74.6)
Hypertension
Yes 24 (60.0) 29 (46.0)
1.91 0.167
No 16 (40.0) 34 (54.0)
ARMD – age-related macular degeneration
Table 2. Plasma lipid levels in patients with presbyopia 
and ARMD
Variable




0.6-2.2 mmol/L 17 (42.5) 47 (74.6) 10.72 0.001>2.2 mmol/L 23 (57.5) 16 (25.4)
Cholesterol
3.5-6.2 mmol/L 11 (27.5) 38 (60.3) 10.56 0.001>6.2 mmol/L 29 (72.5) 25 (39.7)
HDL cholesterol
0.9-1.70 mmol/L 28 (70.0) 31 (49.2) 2.23 0.135>1.70 mmol/L 12 (30.0) 32 (50.8)
LDL cholesterol
2.6-4.10 mmol/L 14 (35.0) 50 (79.4) 12.09 0.001>4.10 mmol/L 26 (65.0) 13 (20.6)
ARMD = age-related macular degeneration; HDL = high-density 
lipoprotein cholesterol; LDL = low-density lipoprotein cholesterol
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Table 3 shows consumption of cigarettes and al-
cohol in patients with ARMD and presbyopia. The 
number of patients who smoked more than one pack 
of cigarettes daily was higher in ARMD group (n=3; 
7.5%) than in control group (n=2; 3.2%), however, 
the difference did not reach statistical significance 
(χ2=1.11; P=0.620). Drinking more than two glasses 
of wine and/or one or more glasses of spirits per day 
was present in 12 (30.0%) ARMD patients and 23 
(36.5%) presbyopia patients. There was no statistically 
significant between-group difference either (χ2=0.416; 
P=0.497). 
The prevalence of positive family history and ex-
posure to sunlight in ARMD and presbyopia patients 
is shown in Table 4. Positive family history of ARMD 
was present in 15 (37.5%) ARMD patients and in one 
(1.59%) patient with presbyopia, the difference being 
statistically significant (χ2=6.64; P=0.010). Sunlight 
exposure was present in a higher number of ARMD 
patients (n=27; 67.5%) as compared to controls (n=32; 
50.8%), but without statistical significance (χ2=2.79; 
P=0.095). 
Table 5 shows relationship between NSAID 
consumption and etiology of ARMD. There were 8 
(20.0%) ARMD patients and 17 (27.0%) presbyopes 
who were constant NSAID drug consumers, but sta-
tistical analysis showed no significant difference be-
tween the two groups (χ2=0.65; P=0.420).
Difference between ARMD and presbyopia pa-
tients according to the results obtained by use of 
the COPE questionnaire subscales is presented in 
Table 6. The COPE questionnaire subscales are 
Persistence, Emotions, Avoidance, Fun and Disar-
rangement. Patients with ARMD showed lower 
indexes in all subscales of the COPE questionnaire 
in comparison to control group, with significant dif-
ference only in the Emotions subscale (Student’s t-
test=2.565; P=0.012). 
Table 7 shows differences in general health charac-
teristics between the study groups. These characteris-
tics were measured by the GHQ questionnaire, which 
included 5 subscales: Somatic symptoms, Anxiety/
insomnia, Social dysfunction, Depression and Total 
score. Patients with ARMD had higher indexes in all 
subscales of the GHQ questionnaire in comparison to 
control group (patients with presbyopia), with signifi-




patients χ2 test P
ARMD Presbyopia
Smoking
No 28 (70.0) 47 (74.6)
1.11* 0.620
<1 pack of 
cigarettes 9 (22.5) 14 (22.2)
>1 pack of 




of wine 28 (70.0) 40 (63.5)
0.416 0.497>2 glasses of 
wine/one/more 
glasses of spirit
12 (30.0) 23 (36.5)
ARMD = age-related macular degeneration; *Fisher exact test
Table 4. Occupation and positive family history of ARMD 
patients
Variable




exposure 13 (32.5) 31 (49.2) 2.79 0.095Sunlight
exposure 27 (67.5) 32 (50.8)
Positive family 
history
Yes 15 (37.5) 1 (1.59) 6.64 0.010No 25 (62.5) 62 (98.41)
ARMD = age-related macular degeneration
Table 5. Use of NSAID in ARMD patients
Variable
Number (%) of patients χ2 
test PARMD Presbyopia
Use of NSAID 
8 (20.0) 17 (27.0) 0.65 0.420
ARMD = age-related macular degeneration; NSAID = nonsteroidal 
anti-inflammatory drugs
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cant difference only in the Social dysfunction subscale 
(Student’s t-test=2.857; P=0.005). 
Discussion
The exact etiology of ARMD is still unknown5. 
It is generally considered that the presence of some 
risk factors, i.e. age, hypertension, hyperlipidemia, 
etc., is associated with the genesis or progression of 
ARMD24,30-33. Results of this study showed that 
95% of ARMD patients were older than 60, which 
confirmed the results found in the international lit-
erature5,8. The mean age of the patients in our study 
was 64±9.8 years; however, ARMD can develop in 
younger adults as well. Numerous studies have shown 
that people older than 60 have a significantly higher 
risk of ARMD, i.e. the incidence of ARMD rises up 
to 30% in people aged 75-8534.
Smoking is a significant and an independent risk 
factor for the development of ARMD. Smoking is 
thought to reduce antioxidant level, decrease luteal 
pigments in the retina and reduce choroidal blood 
flow35. However, current smokers have the highest 
risk of developing ARMD, while former smokers also 
have an increased risk when compared to people who 
Table 6. Results of COPE questionnaire in ARMD and presbyopia patients
COPE Questionnaire 
subscales
Mean ±SD Student’s  
t-test PARMD Presbyopia
Persistence 50.22±5.70 50.76±7.10 0.402 0.688
Emotions 50.50±8.70 55.00±8.66 2.565 0.012
Avoidance 52.57±6.74 54.73±7.71 1.449 0.150
Fun 17.17±2.63 18.00±2.98 1.431 0.156
Disarrangement 24.75±3.97 26.11±4.41 1.584 0.116
COPE = Coping Orientation to Problems Experienced; ARMD = age-related macular degeneration
Table 7. Results of GHQ in patients with ARMD and presbyopia
GHQ subscales
Mean ±SD Student’s  
t-test PARMD Presbyopia
Somatic symptoms 14.55±3.27 13.32±3.07 1.904 0.060
Anxiety/insomnia 14.00±4.73 13.45±4.56 0.583 0.561
Social dysfunction 17.25±3.62 15.32±2.83 2.857 0.005
Depression 9.30±3.79 9.22±3.44 0.301 0.764
Total score 55.11±11.58 51.62±11.23 1.505 0.135
GHQ = General Health Questionnaire; ARMD = age-related macular degeneration
have never smoked31,36. Alcohol consumption causes 
different diseases that pose an important medical and 
social burden in the world today. Daily acceptable 
amount of alcohol varies from country to country; a 
glass of wine or beer and a half glass of liquor contain 
the same amount of alcohol37. It was shown that a high 
level of alcohol consumption (more than 7 drinks per 
week or 3 per occasion) increases the risk of ARMD35. 
Despite the fact that alcohol stands independently as 
a risk factor, we cannot completely exclude its correla-
tion with smoking6.
Our research showed that most of the ARMD 
patients were obese and had high blood pressure. 
Obesity is the leading problem worldwide and it is 
in persistent progress. The mechanism of how obe-
sity (BMI ≥25 kg/m2) increases the risk of ARMD 
development is described by physical changes caused 
by the increasing body weight. These changes include 
a higher level of oxidative stress, imbalance of blood 
lipids, and a higher risk of all inflammatory processes. 
These changes lead to lower production of macular 
pigment (lutein and zeaxanthin) which protects the 
photosensitive cell layer of the retina from harmful 
sunlight effect32,38. People with hypertension are more 
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likely to have ARMD. High blood pressure damages 
blood vessels of the retina causing vasoconstriction. 
Wieberdink et al. and Chen et al. have found that 
hypertension, obesity and high cholesterol levels are 
associated with the increased risk of ARMD39,40. Hy-
pertension can exacerbate the wet form of ARMD, 
particularly the form with retinal neovascularization. 
Antihypertensive drugs do not have direct impact on 
the disease but can slow down its progression41.
Our study recorded significantly higher levels 
of triglycerides, cholesterol and LDL cholesterol in 
the case group. Previous studies have shown that a 
higher serum level of cholesterol increases the risk of 
ARMD42. Over time, cholesterol accumulates in the 
posterior eye segment but its role is still unknown. 
As many details are still missing in the pathogen-
esis of ARMD, it is necessary to keep studying the 
links between hyperlipidemia and ARMD43. Cata-
ract, dry eye syndrome and retinal hemorrhages can 
be induced by constant use of NSAID (acetylsali-
cylic acid and diclofenac). Paracetamol, even if it is 
not considered as a typical NSAID, can also be very 
harmful. There were only a few studies trying to 
prove relationship between the use of NSAID and 
ARMD, and their results are contradictory44. How-
ever, our study showed that long term usage of these 
drugs was not a significant risk factor for develop-
ment of ARMD.
Our results revealed that a significant number of 
cases had positive family history of ARMD. In our 
study, there was no difference between the two groups 
according to sunlight exposure, although some stud-
ies confirmed long term exposure to intense direct 
sunlight as one of the most relevant risk factors for 
ARMD. Bone et al. found that the most damaged site 
on the retina in patients with ARMD was the one 
that had accumulated the most direct light over life-
time45.
Emotional distress and depression are very com-
mon in elderly people suffering from vision loss on one 
or both eyes. ARMD highly reduces the psychosocial 
quality of life causing difficulties with reading, night 
driving, recognizing faces and entering rooms with 
dimmed lights. The negative effects of ARMD on the 
patient’s life are also manifested in the unavoidable 
dependence on help from the others, which increases 
the level of depression24. There are only a few stud-
ies that assessed correlation between chronic stress 
and ARMD25,26. In our study, patients with ARMD 
had significantly worse results in the COPE Emo-
tions subscale. The possible explanation for this might 
be the fact that people with ARMD have some level 
of depression, so their emotional functioning is de-
creased24. Further, in the COPE subscales that mea-
sure persistence, avoidance, fun and disarrangement, 
patients with ARMD also had worse results in com-
parison to presbyopes, but without significant differ-
ence.
With regard to the GHQ subscales, patients with 
ARMD had significantly poorer psychological well-
being (higher score in the Social dysfunction sub-
scale) when compared to control group. Considering 
the results in other GHQ subscales, no statistical dif-
ference was found between the two groups, although 
ARMD patients had higher scores in comparison 
to controls. A higher score of social dysfunction 
in patients with ARMD means that these patients 
are more socially dysfunctional because they are in 
greater need of the others’ help and understanding. 
In general, the lack of free time, along with stress-
ful and fast way of life contributes greatly to social 
dysfunction. ARMD is a disease that affects elderly 
people who are in most cases already retired and 
limited in activities that could improve their social 
functioning46,47.
In conclusion, ARMD is a multiple risk factor 
disease with emphasis on metabolic factors as the 
main cause. Correlation between alcohol consump-
tion and smoking and their cumulative effect on the 
development of ARMD is still unknown, and it is 
necessary to conduct further research to clarify this 
interaction. Also, the quality of life is considerably 
reduced in patients with ARMD, which is the main 
cause of blindness in the elderly, especially if they 
suffer from other ocular or general diseases. De-
creased quality of life can contribute to the develop-
ment of depression, which in addition reduces social 
functioning and pulls the individual into a vicious 
circle. Therefore, it is necessary to conduct additional 
studies in a large number of patients to determine 
more accurately the pathophysiological mechanisms 
of the metabolic factors involved, as well as the im-
pact of the disease on the quality of life in patients 
with ARMD.
Acta Clin Croat,  Vol. 53,   No. 1,  2014 85
I. Ćavar et al. Quality of life and ARMD
References
  1. FRASER-BELL S, WU J, KLEIN R, AZEN SP, HOOP-
ER C, FOONG AW, VARMA R. Cardiovascular risk fac-
tors and age-related macular degeneration: the Los Angeles 
Latino Eye Study. Am J Ophthalmol 2008;145:308-16.
  2. SCHMUCKER C, EHLKEN C, AGOSTINI HT, AN-
TES G, RUECKER G, LELGEMANN M, LOKE YK. A 
safety review and meta-analyses of bevacizumab and ranibi-
zumab: off-label versus gold standard. PLoS One 2012;7.
  3. TUO J, GROB S, ZHANG K, CHAN CC. Genetics of im-
munological and inflammatory components in age-related mac-
ular degeneration. Ocul Immunol Inflamm 2012;20:27-36.
  4. CRABB JW, MIYAGI M, GU X, SHADRACH K, WEST 
KA, SAKAGUCHI H, KAMEI M, HASAN A, YAN 
L, RAYBORN ME, SALOMON RG, HOLLYFIELD 
JG. Drusen proteome analysis: an approach to the etiology 
of age-related macular degeneration. Proc Natl Acad Sci 
USA 2002;99:14682-7.
  5. RYU E, FRIDLEY BL, TOSAKULWONG N, BAILEY 
KR, EDWARDS AO. Genome-wide association analyses 
of genetic, phenotypic, and environmental risks in the age-
related eye disease study. Mol Vis 2010;16:2811-21.
  6. CHONG EW, WONG TY, KREIS AJ, SIMPSON 
JA, GUYMER RH. Dietary antioxidants and primary pre-
vention of age related macular degeneration: systematic re-
view and meta-analysis. BMJ 2007;335:755.
  7. CLEMONS TE, MILTON RC, KLEIN R, SEDDON 
JM, FERRIS FL. Age-Related Eye Disease Study Research 
Group. Risk factors for the incidence of advanced age-related 
macular degeneration in the Age-Related Eye Disease Study 
(AREDS). Ophthalmology 2005;112:533-9.
  8. Van de VEN JP, SMAILHODZIC D, BOON CJ, FAUS-
ER S, GROENEWOUD JM, CHONG NV, HOYNG 
CB, KLEVERING BJ, den HOLLANDER AI. Associa-
tion analysis of genetic and environmental risk factors in the 
cuticular drusen subtype of age-related macular degeneration. 
Mol Vis 2012;18:2271-8.
  9. SARANGARAJAN R, APTE SP. Melanization and phago-
cytosis: implications for age related macular degeneration. 
Mol Vis 2005;11:482-90.
10. FEEHAN M, HARTMAN J, DURANTE R, MORRI-
SON MA, MILLER JW, KIM IK, DeANGELIS MM. 
Identifying subtypes of patients with neovascular age-related 
macular degeneration by genotypic and cardiovascular risk 
characteristics. BMC Med Genet 2011;12:83.
11. OLEA JL, TUÑÓN J. Patients with neovascular age-related 
macular degeneration in Spain display a high cardiovascular 
risk. Eur J Ophthalmol 2012;22:404-11.
12. SAYIN O, ARSLAN N, GUNER G. The protective effects 
of resveratrol on human coronary artery endothelial cell dam-
age induced by hydrogen peroxide in vitro. Acta Clin Cro-
at 2012;51:227-35.
13. MANDIĆ Z, BENČIĆ G, VATAVUK Z. The role of vi-
tamins in the treatment of age-related macular degenera-
tion. Acta Clin Croat 2002;43:321-6.
14. CHAKRAVARTHY U, WONG TY, FLETCHER 
A, PIAULT E, EVANS C, ZLATEVA G, BUGGAGE 
R, PLEIL A, MITCHELL P. Clinical risk factors for age-
related macular degeneration: a systematic review and meta-
analysis. BMC Ophthalmol 2010;10:31.
15. TANAKA K, NAKAYAMA T, YUZAWA M, WANG 
Z, KAWAMURA A, MORI R, NAKASHIZUKA 
H, SATO N, MIZUTANI Y. Analysis of candidate genes 
for age-related macular degeneration subtypes in the Japanese 
population. Mol Vis 2011;17:2751-8.
16. YOU QS, XU L, YANG H, LI YB, WANG S, WANG 
JD, ZHANG JS, WANG YX, JONAS JB. Five-year inci-
dence of age-related macular degeneration: the Beijing Eye 
Study. Ophthalmology 2012;119:2519-25.
17. RENZI LM, HAMMOND BR Jr, DENGLER M, ROB-
ERTS R. The relation between serum lipids and lutein and 
zeaxanthin in the serum and retina: results from cross-sec-
tional, case-control and case study designs. Lipids Health 
Dis 2012;11:33.
18. DEMARIN V, LISAK M, MOROVIĆ S, ČENGIĆ T. 
Low high-density lipoprotein cholesterol as the possible risk 
factor for stroke. Acta Clin Croat 2010;49:429-39.
19. MINISZEWSKA J, CHODKIEWICZ J, ZALEWSKA-
JANOWSKA A. Quality of life in health and disease – what 
is it, how and why evaluate it. Przegl Lek 2012;69:253-9.
20. AUGUSTIN A, SAHEL JA, BANDELLO F, DARDE-
NNES R, MAUREL F, NEGRINI C, HIEKE K, BER-
DEAUX G. Anxiety and depression prevalence rates in 
age-related macular degeneration. Invest Ophthalmol Vis 
Sci 2007;48:1498-503.
21. BRODY BL, FIELD LC, ROCH-LEVECQ AC, MOUTI-
ER CY, EDLAND SD, BROWN SI. Treatment of depres-
sion associated with age-related macular degeneration: a 
double-blind, randomized, controlled study. Ann Clin Psy-
chiatry 2011;23:277-84.
22. MATHEW RS, DELBAERE K, LORD SR, BEAU-
MONT P. VAEGAN, MADIGAN MC. Depressive symp-
toms and quality of life in people with age-related macular 
degeneration. Ophthalmic Physiol Opt 2011;31:375-80.
23. ŠIAUDVYTYTĖ L, MITKUTĖ D, BALČIŪNIENĖ J. 
Quality of life in patients with age-related macular degenera-
tion. Medicina (Kaunas) 2012;48:109-11.
24. WILLIAMS RA, BRODY BL, THOMAS RG, KAPLAN 
RM, BROWN SI. The psychosocial impact of macular de-
generation. Arch Ophthalmol 1998;6:514-20.
25. MEYER-RUESENBERG B, RICHARD G. New insights 
into the underestimated impairment of quality of life in age-
related macular degeneration – a review of the literature. Klin 
Monatsbl Augenheilkd 2010;227:646-52.
86 Acta Clin Croat,  Vol. 53,   No. 1,  2014
I. Ćavar et al. Quality of life and ARMD
26. WAHL HW, HEYL V, LANGER N. Quality of life by 
limited vision in old age: the example of age-related macula 
degeneration. Ophthalmologe 2008;105:735-43.
27. MIELKE A, WIRKUS K, NIEBLER R, ESCHWEILER 
G, NGUYEN NX, TRAUZETTEL-KLOSINSKI S. The 
influence of visual rehabilitation on secondary depressive dis-
orders due to age-related macular degeneration: a randomized 
controlled pilot study. Ophthalmologe 2013;110:433-40.
28. COSWAY R, ENDLER NS, SADLER AJ, DEARY IJ. The 
Coping Inventory for Stressful Situations: factorial structure 
and associations with personality traits and psychological 
health. J Appl Biobehav Res 2000;5:121-43.
29. NAGYOVA I, STEWART RE, MACEJOVA Z, van DIJK 
JP, van den HEUVEL WJ. The impact of pain on psycho-
logical well-being in rheumatoid arthritis: the mediating ef-
fects of self-esteem and adjustment to disease. Patient Educ 
Couns 2005;58:55-62.
30. POKHAREL S, MALLA OK, PRADHANANGA 
CL, JOSHI SN. A pattern of age-related macular degenera-
tion. JNMA J Nepal Med Assoc 2009;48:217-20.
31. CONG R, ZHOU B, SUN Q , GU H, TANG N, WANG 
B. Smoking and the risk of age-related macular degeneration: 
a meta-analysis. Ann Epidemiol 2008;18:647-56.
32. MOEINI HA, MASOUDPOUR H, GHANBARI H. A 
study of the relation between body mass index and the in-
cidence of age related macular degeneration. Br J Ophthal-
mol 2005;89:964-6.
33. CHIANG CE, WANG TD, LI YH, LIN TH, CHIEN 
KL, YEH HI, SHYU KG, TSAI WC, CHAO TH, HWANG 
JJ, CHIANG FT, CHEN JH. Hypertension Committee of 
the Taiwan Society of Cardiology 2010 guidelines of the Tai-
wan Society of Cardiology for the management of hyperten-
sion. J Formos Med Assoc 2010;109:740-73.
34. AKPEK EK, SMITH RA. Overview of age-related ocular 
conditions. Am J Manag Care 2013;19:67-75.
35. KLEIN R, CRUICKSHANKS KJ, NASH SD, KRANTZ 
EM, NIETO FJ, HUANG GH, PANKOW JS, KLEIN 
BE. The prevalence of age-related macular degeneration and 
associated risk factors. Arch Ophthalmol 2010;128:750-8.
36. CHO E, HANKINSON SE, WILLETT WC, STAMP-
FER MJ, SPIEGELMAN D, SPEIZER FE, RIMM 
EB, SEDDON JM. Prospective study of alcohol consump-
tion and the risk of age-related macular degeneration. Arch 
Ophthalmol 2000;118:681-8.
37. HERREROS-VILLANUEVA M, HIJONA E, BAÑALES 
JM, COSME A, BUJANDA L. Alcohol consumption on 
pancreatic diseases. World J Gastroenterol 2013;19:638-47.
38. MEYERS KJ, JOHNSON EJ, BERNSTEIN PS, IYEN-
GAR SK, ENGELMAN CD, KARKI CK, LIU Z, IGO RP 
Jr, TRUITT B, KLEIN ML, SNODDERLY DM, BLODI 
BA, GEHRS KM, SARTO GE,WALLACE RB, ROB-
INSON J, LEBLANC ES, HAGEMAN G, TINKER 
L, MARES JA. Genetic determinants of macular pigments 
in women of the Carotenoids in Age-Related Eye Disease 
Study. Invest Ophthalmol Vis Sci 2013;54:2333-45.
39. WIEBERDINK RG, HO L, IKRAM MK, KOUD-
STAAL PJ, HOFMAN A, de JONG PT, VINGERLING 
JR, BRETELER MM. Age-related macular degeneration and 
the risk of stroke: the Rotterdam Study. Stroke 2011;42:2138-
42. 
40. CHEN Y, ZENG J, ZHAO C, WANG K, TROOD 
E, BUEHLER J, WEED M, KASUGA D, BERNSTEIN 
PS, HUGHES G, FU V, CHIN J, LEE C, CROCKER 
M, BEDELL M, SALASAR F, YANG Z, GOLDBAUM 
M, FERREYRA H, FREEMAN WR, KOZAK I, ZHANG 
K. Assessing susceptibility to age-related macular degenera-
tion with genetic markers and environmental factors. Arch 
Ophthalmol 2011;129:344-51.
41. JONES AA. Age related macular degeneration – should your 
patients be taking additional supplements? Aust Fam Physi-
cian 2007;36:1026-8.
42. KOVAČEVIĆ D, ČALJKUŠIĆ-MANCE T, MIŠLJENO-
VIĆ T, MIKULIČIĆ M, ALPEZA-DUNATO Z. Intravi-
treal bevacizumab for the management of age-related macu-
lar degeneration. Coll Antropol 2008;322:5-7.
43. LIU M, REGILLO CD. A review of treatments for macular 
degeneration: a synopsis of currently approved treatments and 
ongoing clinical trials. Curr Opin Ophthalmol 2004;15:221-6.
44. KIERNAN DF, HARIPRASAD SM, RUSU IM, MEH-
TA SV, MIELER WF, JAGER RD. Epidemiology of the 
association between anticoagulants and intraocular hemor-
rhage in patients with neovascular age-related macular de-
generation. Retina 2010;30:1573-8.
45. BONE RA, GIBERT JC, MUKHERJEE A. Light distribu-
tions on the retina: relevance to macular pigment photopro-
tection. Acta Biochim Pol 2012;59:91-6.
46. STEIN JD, BROWN MM, BROWN GC, HOLLANDS 
H, SHARMA S. Quality of life with macular degeneration: 
perceptions of patients, clinicians, and community mem-
bers. Br J Ophthalmol 2003;87:8-12.
47. EVANS K, LAW SK, WALT J, BUCHHOLZ P, HAN-
SEN J. The quality of life impact of peripheral versus central 
vision loss with a focus on glaucoma versus age-related macu-
lar degeneration. Clin Ophthalmol 2009;3:433-45.
Acta Clin Croat,  Vol. 53,   No. 1,  2014 87
I. Ćavar et al. Quality of life and ARMD
Sažetak
METABOLIČKI ČIMBENICI RIZIKA, SUOČAVANJE SA STRESOM I PSIHOLOŠKO ZDRAVLJE U 
BOLESNIKA SA SENILNOM MAKULARNOM DEGENERACIJOM
I. Ćavar, S. Lovrić, M. Vukojević, I. Sesar, I. Petric-Vicković i A. Sesar
Cilj ovoga istraživanja bio je utvrditi povezanost između rizičnih čimbenika (dob, pretilost, hipertenzija, hiperlipide-
mija, pušenje, konzumacija alkohola i lijekova, pozitivna obiteljska anamneza, izloženost sunčevom zračenju), suočavanja 
sa stresom, psihološkog aspekta kvalitete života i senilne makularne degeneracije (SMD). U istraživanje su bili uključeni 
bolesnici oboljeli od SMD (n=40) koji su činili ispitivanu skupinu i prezbiopi (n=63) koji su činili kontrolnu skupinu. 
Podatci su se prikupili ispunjavanjem upitnika kojim su se dobili opći podatci i opisale navike bolesnika, upitnika COPE 
kojim su se ispitali načini reagiranja na stres te upitnika GHQ kojim se analizirao psihološki aspekt kvalitete života. Na-
vedeni upitnici bili su osobno uručeni ispitanicima prilikom oftalmološkog pregleda. U istraživanje je bilo uključeno 46 
(44,66%) muškaraca i 57 (55,33%) žena. Statistička obradba pokazala je da najveći rizik za obolijevanje od SMD predstav-
ljaju povišene razine kolesterola, triglicerida i LDL kolesterola u krvi. Značajno veći broj bolesnika u ispitivanoj skupini 
imao je pozitivnu obiteljsku anamnezu u odnosu na kontrolnu skupinu. Ovo istraživanje pokazalo je da prezbiopi značajno 
bolje reagiraju u osjećajima usmjerenom suočavanju te da imaju niži stupanj socijalne disfunkcije u odnosu na bolesnike 
oboljele od SMD. Međutim, potrebno je provesti daljnja istraživanja na velikom broju bolesnika kako bi se točnije utvrdili 
patofiziološki mehanizmi metaboličkih čimbenika, kao i utjecaj bolesti na kvalitetu života u bolesnika sa SMD.
Ključne riječi: Žuta pjega, degeneracija; Starenje; Čimbenici rizika; Adaptacija, psihološka; Kvaliteta života
